Premium
Treatment of a case of feline infectious peritonitis with cyclosporin A
Author(s) -
Tanaka Yoshikazu,
Sato Yuka,
Takahashi Daiki,
Matsumoto Hirotaka,
Sasaki Takashi
Publication year - 2015
Publication title -
veterinary record case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.165
H-Index - 4
ISSN - 2052-6121
DOI - 10.1136/vetreccr-2014-000134
Subject(s) - medicine , feline infectious peritonitis , infectious disease (medical specialty) , middle east respiratory syndrome , peritonitis , respiratory system , virology , immunology , in vivo , coronavirus , covid-19 , disease , microbiology and biotechnology , biology
Feline infectious peritonitis is a fatal viral disease which is currently incurable by drugs. Also, there are no effective vaccines. Cyclosporin A (CsA) was recently shown in vitro to exert potent antiviral activities on several virus‐host systems, including various coronaviruses. However, whether CsA has clinically relevant activity in vivo resistant to various coronaviruses, including the severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses, remains unknown. Herein, the authors report that treatment with CsA caused a sustained reduction in pleural fluid volume and viral copy number in a cat diagnosed with effusive feline infectious peritonitis.